These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8769031)

  • 1. 1996 National Heart Foundation clinical guidelines for the assessment and management of dyslipidaemia. Dyslipidaemia Advisory Group on behalf of the scientific committee of the National Heart Foundation of New Zealand.
    N Z Med J; 1996 Jun; 109(1024):224-31. PubMed ID: 8769031
    [No Abstract]   [Full Text] [Related]  

  • 2. New Zealand guidelines for the management of dyslipidaemia: implications for treatment in an urban New Zealand population.
    North D; Priest P; Lay-Yee R; Jackson R
    N Z Med J; 1996 Apr; 109(1020):134-7. PubMed ID: 8649667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guidelines on blood lipid screening and management of hyperlipidaemia. National Health Foundation of New Zealand Advisory Group.
    N Z Med J; 1988 Oct; 101(855):629-32. PubMed ID: 3173873
    [No Abstract]   [Full Text] [Related]  

  • 4. Guidelines for detection and management of dyslipidaemia. Scientific Committee of the National Heart Foundation of New Zealand.
    Mann JI; Crooke M; Fear H; Hay DR; Jackson RT; Neutze JM; White HD
    N Z Med J; 1993 Apr; 106(953):133-41. PubMed ID: 8474734
    [No Abstract]   [Full Text] [Related]  

  • 5. NHF guidelines on the management of dyslipidaemia.
    Mann J; Agnew T
    N Z Med J; 1996 Sep; 109(1029):345. PubMed ID: 8862356
    [No Abstract]   [Full Text] [Related]  

  • 6. Reducing CVD risk - integration of clinical and laboratory criteria.
    Tognarini DP; Sullivan DR; Thomas DW; Sikaris K
    Aust Fam Physician; 2008 Jun; 37(6):422-7. PubMed ID: 18523695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: position statement on lipid management--2005.
    Tonkin A; Barter P; Best J; Boyden A; Furler J; Hossack K; Sullivan D; Thompson P; Vale M; Cooper C; Robinson M; Clune E; ;
    Heart Lung Circ; 2005 Dec; 14(4):275-91. PubMed ID: 16361000
    [No Abstract]   [Full Text] [Related]  

  • 8. Coronary heart disease. A New Zealand report, 1971 National Heart Foundation of New Zealand.
    N Z Med J; 1971 Oct; 74(473):262-7. PubMed ID: 5289182
    [No Abstract]   [Full Text] [Related]  

  • 9. The hyperlipidemias.
    Cox RA
    Bol Asoc Med P R; 2003; 95(5):36-44. PubMed ID: 15008360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Management of dyslipidemias diagnosed in general practice in France--The PRAGMA Study].
    Amouyel P; Farnier M; Lyon G; Siest G; Mortier N; Amiot N; Duprat-Lomon I
    Arch Mal Coeur Vaiss; 2001 Oct; 94(10):1045-53. PubMed ID: 11725709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of dyslipidemia in adults.
    Ahmed SM; Clasen ME; Donnelly JE
    Am Fam Physician; 1998 May; 57(9):2192-2204, 2207-8. PubMed ID: 9606309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Socioeconomic status and dyslipidaemia in a South Indian population: the Chennai Urban Population Study (CUPS 11).
    Pradeepa R; Deepa R; Rani SS; Premalatha G; Saroja R; Mohan V
    Natl Med J India; 2003; 16(2):73-8. PubMed ID: 12816185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmaceutical company sponsorship.
    Mann J; Crooke M; Fear H; Hay D; Jackson R; Neutze J; White H
    N Z Med J; 1993 Jul; 106(960):318. PubMed ID: 8341462
    [No Abstract]   [Full Text] [Related]  

  • 14. A high risk score for coronary heart disease is associated with the metabolic syndrome in 40-year-old men and women.
    Tonstad S; Hjermann I
    J Cardiovasc Risk; 2003 Apr; 10(2):129-35. PubMed ID: 12668910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The national cholesterol education program adult treatment panel ill guidelines.
    Clearfield MB
    J Am Osteopath Assoc; 2003 Jan; 103(1 Suppl 1):S1-5. PubMed ID: 12572622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of dyslipidemia in the high-risk patient.
    Stein EA
    Am Heart J; 2002 Dec; 144(6 Suppl):S43-50. PubMed ID: 12486415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of hypercholesterolaemia in the patient with diabetes.
    Packard C; Olsson AG
    Int J Clin Pract Suppl; 2002 Jul; (130):27-32. PubMed ID: 12296606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Standardization of lipoprotein reporting.
    Kroll MH; Cole TG; Rifai N; Cooper G; Warnick GR; Jialal I
    Am J Clin Pathol; 2000 Nov; 114(5):696-702. PubMed ID: 11068542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of dyslipidemia.
    Akel MM; Salti I
    J Med Liban; 2001; 49(5):274-8. PubMed ID: 12243421
    [No Abstract]   [Full Text] [Related]  

  • 20. Low adherence of General Practitioners to National Cholesterol Education Program guidelines for the management of hyperlipidaemia.
    Fornengo P; Bruno G; De Salvia A; Arcari R; Pisu E; Pagano G
    Diabetes Nutr Metab; 2000 Oct; 13(5):263-8. PubMed ID: 11105968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.